Dr. MiltieAtlas by Dr. Miltie™Healthcare Grant Intelligence
Active — Willing & Qualified ContractingAtlas Opportunity Score 92/100

Maine DHHS Overdose Prevention & Naloxone Distribution — Willing & Qualified Contracting Pathway

FundingCurrent PJF attachment lists four incumbent agreements totaling $7,188,060 through June 30, 2027. These are existing contract values, not a published ceiling or guaranteed amount for an additional provider.
DeadlineActive Willing & Qualified posting through June 30, 2027. The State does not publish a separate application deadline, closing clock time, or time zone; interested qualified providers are directed to the Department contract administrator listed in the PJF.
Last verifiedSeptember 19, 2026
Required next actionTreat MaineGeneral Medical Center, the City of Portland, the City of Bangor, and Maine Access Points as incumbent contract holders, not unsent applicants for this exact W&Q pathway. For any additional prospective provider, first confirm the exact overdose-prevention and/or Tier 1 naloxone-distribution service model, trained staffing, regional capacity, public-health/harm-reduction qualifications, and current incremental contracting/funding availability with the DHHS contract administrator. Then complete canonical CRM Contact/Lead/Deal, Email Opt-Out, and actual sent-history deduplication before outreach. The PJF narrative's municipal-public-health-agency wording is not treated as a universal gate because the attached current vendor list includes non-municipal organizations; confirm eligibility directly with DHHS rather than inferring it.

Broad Eligibility

Prospective providers must be willing to deliver the State's overdose-prevention and/or naloxone-distribution services and meet the published minimum service qualifications, including trained staff, sufficient resources, high-risk-population outreach capacity, and, for Tier 1 naloxone distribution, capacity to purchase and distribute large quantities of naloxone kits. The PJF narrative's municipal-public-health-agency wording conflicts with the composition of the attached current vendor list, so Atlas does not infer municipal status as a universal eligibility requirement without DHHS confirmation.

Atlas Analysis

Atlas Opportunity Score: 92/100. N9+ Fit Score: 0/100. This is a strong Maine behavioral-health, substance-use, harm-reduction, and overdose-prevention contracting pathway, but the controlling scope is outreach, education, naloxone procurement/distribution, and program staffing rather than remote-examination or diagnostic technology. Dr. Miltie direct-vendor fit is 0/100 on current records because the required public-health/harm-reduction service qualifications and operational capacity are not established.

Opportunity Overview

The Maine Department of Health and Human Services, Office of Behavioral Health maintains an active Willing & Qualified contracting pathway for statewide overdose-prevention education, outreach, and naloxone distribution under CT NOI 1020250900. Maine Procurement Services states that services listed under the Willing & Qualified framework may be provided by multiple vendors that agree to the standard service requirements and meet the State’s minimum qualification criteria.

Active Period and Funding

The State’s current Willing & Qualified listing shows this pathway posted through June 30, 2027. The controlling Procurement Justification Form covers agreements from July 1, 2025 through June 30, 2027. It does not publish a separate application deadline, closing clock time, or time zone; vendors interested in providing the described services are directed to the Department contract administrator listed on the PJF.

The current PJF attachment lists four agreements totaling $7,188,060. Those amounts are current incumbent contract values, not a published ceiling or guaranteed amount for an additional provider.

Service Scope

The overdose-prevention component includes education and outreach to high-risk populations, coordination of regional community outreach, and evidence-based prevention information for communities, providers, and at-risk clients. The naloxone-distribution component supports purchase and distribution of intranasal Narcan and intramuscular naloxone, overdose-response education, rescue-kit distribution, and related qualified staffing.

Qualification Controls

The PJF states that selected providers have trained staff, resources, and the ability to deliver overdose-prevention outreach to high-risk groups, including people in Medication Assisted Treatment, recovery-support, and harm-reduction programs. For naloxone distribution, the current providers are described as Tier 1 providers capable of purchasing and distributing large quantities of naloxone kits to Tier 2 community providers.

The PJF narrative also describes the selected providers as municipal public health agencies, while its current attachment lists MaineGeneral Medical Center and Maine Access Points in addition to the Cities of Portland and Bangor. Atlas therefore does not infer that municipal status is a universal eligibility gate for every future W&Q provider. Any prospective provider should confirm the controlling minimum qualifications directly with the Department contract administrator before outreach or record creation.

Current Contract Holders

The current attachment lists MaineGeneral Medical Center, the City of Portland, the City of Bangor, and Maine Access Points. These entities are incumbent contract holders for this exact pathway and should not receive initial opportunity outreach merely to announce funding they already hold.

Atlas Assessment

Atlas Opportunity Score: 92/100. This is a substantial statewide behavioral-health, harm-reduction, and overdose-prevention contracting pathway with a public Willing & Qualified route for additional providers that can satisfy the State’s service and qualification controls.

N9+ Fit Score: 0/100. The controlling scope is overdose-prevention outreach, naloxone procurement/distribution, education, and related staffing. It does not establish a remote-examination, diagnostic-device, telehealth-platform, or N9+ procurement path.

Dr. Miltie direct-vendor fit: 0/100 on current records. Atlas has not established the public-health, naloxone-distribution, harm-reduction, staffing, or other program qualifications necessary to act as a prime provider.

Next Action

For any additional prospective Maine provider, first confirm the exact overdose-prevention and/or Tier 1 naloxone-distribution service model, trained staffing, regional capacity, public-health/harm-reduction qualifications, and current contracting/funding availability with the DHHS contract administrator. Then complete canonical CRM Account, Contact, Lead, exact-opportunity Deal, Email Opt-Out, and actual sent-history deduplication before any outreach. Do not initiate routine initial outreach to the four incumbent contract holders for this exact W&Q pathway.

Source verificationOfficial government source · www.maine.govAtlas last verified this record September 19, 2026. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗